Update Fall 2016 Vitamin D Receptor test costs $29
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists – 2015, To Identify Emerging Players with Potentially Strong Product Information and Create Effective Counter-Strategies
APRIL 6TH, 2016 RESEARCHMOZ GLOBAL PVT LTD RELEASES, ResearchMoz
Report date is unclear: May 2015 or April 2016
- Category VDR has
530 items The TOP articles in Vitamin D Receptor are listed here:
- Long-COVID is now the biggest COVID concern - many studies
- Preeclampsia reduced by Vitamin D - many studies
- Lung Cancer is up to 7 X more deadly if poor vitamin D genes – Oct 2021
- Vitamin D levels in cells, not blood, is important (IVF follicular fluid in this case) – Aug 2021
- Colon cancer risk increases 30X if you have the worst vitamin D receptor mutation – Jan 2021
- AI is examining 170,000 potential COVID-19 treatments, Vitamin D is one of only 6 found – Sept 4, 2020
- Does survival of the less fit mean less health (poor genes may be inherited)
- Obesity associated with poor Vitamin D genes (VDR in this study) – Jan 2018
- Alzheimer’s is associated with all 7 of the genes which restrict vitamin D from getting to tissues – Sept 2018
- Breast Cancer death 1.8 X more likely if poor Vitamin D Receptor – April 2019
- Vitamin D receptor (TT), which restricts Vit D to cells, is associated with balance problems in seniors – June 2018
- Cerebral small vessel disease 2.5 X more likely if poor Vitamin D Receptor – Sept 2018
- Obesity in 700 young adults associated with a poor Vitamin D Receptor – Jan 2018
- Health problems that run in families are often associated with low vitamin D
- Many autoimmune diseases associated with latitude and vitamin D receptor – March 2016
- Vitamin D and the skin: Focus on a complex relationship - Nov 2015
- Benefits of Vitamin D often limited by genes
- 2X more Parkinson's disease if modified vitamin D receptor genes – meta-analysis Aug 2014
- Pancreatic Cancer massively deregulates the local Vitamin D receptors and CPY24A1 – July 2014
- Death from melanoma (without ulcers) greatly decreased if have lots of vitamin D receptors – May 2014
- 13 reasons why many seniors need more vitamin D (both dose and level) - July 2023
- Vitamin D level can be high, but little benefit: due to kidney, genes, low Magnesium etc.
DelveInsight’s, Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.DelveInsight’s, Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists- Pipeline Insights, 2015 Report covers the Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists.
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=290606
Scope
- DelveInsight’s report provides a Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists Landscape across the globe
- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
- Coverage of the Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists and also provide company profiling
- Pipeline products coverage based on various stages of development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Table of Content- Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists
Overview
Disease Associated
Pipeline Therapeutics
Therapeutics under Development by Companies
Late Stage Products (Filed and Phase III) - Comparative Analysis: Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists
Mid Clinical Stage Products (Phase II)
Early Clinical Stage Products (Phase I and IND Filed)
Discovery and Pre-Clinical Stage Products
Drug Candidate Profiles
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales at researchmoz.us
http://www.researchmoz.us/Vitamin D Receptor report costs 1250 dollars – May 2015Printer Friendly Follow this page for updates2442 visitors, last modified 24 Dec, 2016,